Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-15
2006-08-15
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S019300, C530S324000, C530S325000, C530S326000, C530S327000, C530S328000, C530S329000, C530S330000
Reexamination Certificate
active
07091185
ABSTRACT:
One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%.
REFERENCES:
patent: 5114921 (1992-05-01), Zasloff
patent: 5789384 (1998-08-01), Khavinson et al.
patent: 5789542 (1998-08-01), McLaughlin et al.
patent: 5856435 (1999-01-01), Bazile et al.
patent: 6448391 (2002-09-01), Garbarino et al.
patent: 6531446 (2003-03-01), Kim et al.
Chen et al., American Jounral of Veterinary Research, 2003, 64(9), 1088-92.
Seipke et al., International Journal of Biological Macromolecules, 1980, 2(4), pp. 268-270.
Durell SR, et al., “Modeling the ion channel structure of cecropin”, Biophys J., Dec., 1992 63(6):1623-31.
E. Gazit, et al., Interaction of the Mammalian Antibacterial Peptide Cecropin P1 with Phospholipid Vesicles, Biochemistry, 1995, 34:11479.
Arlotti et al., Efficacy of a synthetic lytic peptide in the treatment of prostate cancer, Urol Oncol., 2001, 6(3): 97-102.
Javadpour, et al., De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity, J. Med. Chem., 1996, 39(16): 3107-3113.
Wachinger, et al., “Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression”, J.Gen. Virol., 1998, (79): 731-740.
Jia Ma, et al., “Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro”, J. Virol., 2002, 76(19): 9952-9961.
S.E. Blondelle and Karl Lohner, “Biopolymers (Peptide Science)”, 2000, vol. 55, 74-87.
Niidome et al., Required Structure of Cationic Peptide for Oligonucleotide-Binding and Delivering Into Cells, 2000, Journal of Peptide Science, vol. 6, No. 6, pp. 271-279.
Brondsema Philip J.
Strom Robert M.
Dow Global Technologies Inc.
Noakes Suzanne M.
Wax Robert A.
LandOfFree
Periodic antimicrobial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Periodic antimicrobial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Periodic antimicrobial peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3666527